About this document "2025 12 xx History PSA MRD T.jpg": What is my MRD and mets as of latest readings
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I can see this document contains a graphical tracking of PSA (Prostate-Specific Antigen) measurements over time, which is commonly used to monitor prostate cancer treatment response and detect potential recurrence.
What These Terms Generally Mean:
PSA (Prostate-Specific Antigen): A protein produced by both normal and cancerous prostate cells. Doctors use PSA blood tests to monitor disease activity. Rising PSA levels after treatment may indicate cancer recurrence, while stable or declining levels generally suggest good treatment response.
MRD (Minimal Residual Disease): In prostate cancer, this refers to very small amounts of cancer that may remain after treatment but aren't detectable by standard imaging. Ultra-sensitive PSA tests can sometimes detect MRD before it becomes visible on scans.
Mets (Metastases): Cancer that has spread from the prostate to other parts of the body, most commonly bones or lymph nodes.
🚨 Important - I Cannot Interpret Your Results
I cannot determine your MRD status or metastatic disease status from this document because:
- Interpreting individual PSA trends requires your complete clinical context
- MRD and metastatic status require correlation with imaging studies, physical exam, and other clinical factors
- Your doctor needs to evaluate PSA values alongside your treatment history, symptoms, and other test results
- The document notes some data ranges as "lost," which affects interpretation
Critical Questions to Ask Your Doctor:
-
About PSA trends: "What does my current PSA level indicate about my disease status? How does this compare to my previous readings?"
-
About MRD: "Based on my PSA levels and imaging, do I have evidence of minimal residual disease? What does this mean for my treatment plan?"
-
About metastases: "Do my current tests show any evidence of metastatic disease? What imaging or additional tests would help clarify this?"
-
About monitoring: "How often should we monitor my PSA? What PSA level or trend would trigger a change in my treatment approach?"
-
About next steps: "Given my current PSA pattern, what are the recommended next steps according to current NCCN Guidelines for prostate cancer monitoring?"
According to NCCN Guidelines for Prostate Cancer, PSA monitoring schedules and interpretation depend on your specific treatment history, initial disease stage, and risk category—factors only your oncologist can evaluate with your complete [ID removed]
This information is for educational purposes only. I cannot interpret your individual results. Please discuss these specific findings with your healthcare team for personalized medical guidance and to understand your current MRD and metastatic status.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ